Virlam 300 mg FC tablets
PDF Leaflet Revision Date: 09 February 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV-infected adults over 18 years.
Dosage (summary)
1 tablet orally with food once daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy or breastfeeding.
Key Drug Interactions
- Didanosine
- Abacavir
- Emtricitabine
Contraindications
- Hypersensitivity
- Moderate to severe renal impairment
- Under 18 years
- Pregnancy
- Lactation
Common side effects
- Dizziness
- Nausea
- Diarrhoea
- Fatigue
- Rash
Counselling Points
- Take with food
- Monitor for signs of lactic acidosis
- Avoid alcohol
Serious warnings
- Lactic acidosis
- Severe hepatomegaly
- Pancreatitis
Important Disclaimer
The Virlam 300 mg FC tablets professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
